{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:06:07Z","timestamp":1792609567271,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T00:00:00Z","timestamp":1639526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jfo.2021.08.016","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T17:13:22Z","timestamp":1649870002000},"page":"495-503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["D\u00e9pistage et pr\u00e9vention des neuropathies optiques toxiques aux anti-mycobact\u00e9riens\u00a0: proposition de recommandations"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2585-2114","authenticated-orcid":false,"given":"C.","family":"Orssaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2020-7052","authenticated-orcid":false,"given":"D.T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Rouzaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Pavie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Pinot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3563-5482","authenticated-orcid":false,"given":"D.","family":"Bremond-Gignac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.P.","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2021.08.016_bib0335","series-title":"Global tuberculosis report 2018","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.jfo.2021.08.016_bib0340","series-title":"Treatment of tuberculosis guidelines","author":"World Health Organization","year":"2009"},{"key":"10.1016\/j.jfo.2021.08.016_bib0345","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.antinf.2014.10.003","article-title":"Traitement des infections \u00e0 Mycobacterium avium complex","volume":"16","author":"Renvois\u00e9","year":"2014","journal-title":"J Anti-Infect"},{"key":"10.1016\/j.jfo.2021.08.016_bib0350","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2017-210927","article-title":"British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)","volume":"72","author":"Haworth","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.jfo.2021.08.016_bib0355","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.rmr.2011.02.016","article-title":"Diagnostic et traitement des mycobact\u00e9rioses atypiques d\u2019expression respiratoire","volume":"28","author":"Andr\u00e9jak","year":"2011","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.jfo.2021.08.016_bib0360","doi-asserted-by":"crossref","first-page":"447","DOI":"10.5588\/ijtld.11.0766","article-title":"Incidence of ethambutol-related visual impairment during treatment of active tuberculosis","volume":"17","author":"Ezer","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jfo.2021.08.016_bib0365","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1136\/bjo.2004.065656","article-title":"Multifocal ERG in ethambutol associated visual loss","volume":"89","author":"Behbehani","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.016_bib0370","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.kjms.2015.05.004","article-title":"Incidence and prognostic factor of ethambutol-related optic neuropathy: 10-year experience in southern Taiwan","volume":"31","author":"Chen","year":"2015","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.jfo.2021.08.016_bib0375","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/OPX.0000000000001216","article-title":"Case report: linezolid optic neuropathy and proposed evidenced-based screening recommendation","volume":"95","author":"Dempsey","year":"2018","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.jfo.2021.08.016_bib0380","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s13312-010-0083-5","article-title":"Bilateral optic neuritis due to isoniazid (INH)","volume":"47","author":"Kulkarni","year":"2010","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.jfo.2021.08.016_bib0385","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1001\/jama.1957.02980160012003","article-title":"Isoniazid as a cause of optic neuritis and atrophy","volume":"164","author":"Kass","year":"1957","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.jfo.2021.08.016_bib0390","doi-asserted-by":"crossref","first-page":"586","DOI":"10.2174\/1381612823666170124113826","article-title":"An updated review on the most common agents causing toxic optic neuropathies","volume":"23","author":"Wasinska-Borowiec","year":"2017","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jfo.2021.08.016_bib0395","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1089\/jop.2011.0095","article-title":"Visual function in patients on ethambutol therapy for tuberculosis","volume":"28","author":"Kandel","year":"2012","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jfo.2021.08.016_bib0400","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/aos.12515","article-title":"Toxic optic neuropathies: an updated review","volume":"93","author":"Grzybowski","year":"2015","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.016_bib0405","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/ICU.0000000000000416","article-title":"Ethambutol optic neuropathy","volume":"28","author":"Chamberlain","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.016_bib0410","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s00417-015-3150-8","article-title":"Longitudinal analysis of retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in ethambutol-induced optic neuropathy","volume":"253","author":"Han","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.016_bib0415","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/WNO.0b013e31818e3c6b","article-title":"Incidence and clinical features of ethambutol-induced optic neuropathy in Korea","volume":"28","author":"Lee","year":"2008","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.jfo.2021.08.016_bib0420","first-page":"56","article-title":"Ocular toxicity of ethambutol","volume":"12","author":"Chan","year":"2006","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.jfo.2021.08.016_bib0425","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10792-009-9293-z","article-title":"Risk factors for ethambutol optic toxicity","volume":"30","author":"Talbert Estlin","year":"2010","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.016_bib0430","doi-asserted-by":"crossref","first-page":"261","DOI":"10.5588\/ijtld.15.0275","article-title":"Incidence of toxic optic neuropathy with low-dose ethambutol","volume":"20","author":"Yang","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jfo.2021.08.016_bib0435","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/WNO.0b013e3182901969","article-title":"Drug-related mitochondrial optic neuropathies","volume":"33","author":"Wang","year":"2013","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.jfo.2021.08.016_bib0440","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.prrv.2010.09.005","article-title":"Treatment of paediatric TB: revised WHO guidelines","volume":"12","author":"Graham","year":"2011","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jfo.2021.08.016_bib0445","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.sjopt.2018.10.010","article-title":"Linezolid-induced optic neuropathy in a child treated for extensively drug resistant tuberculosis: a case report and review of literature","volume":"33","author":"Agashe","year":"2019","journal-title":"Saudi J Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.016_bib0450","doi-asserted-by":"crossref","first-page":"e341","DOI":"10.1111\/aos.13237","article-title":"Clinical recovery in linezolid-induced optic nerve toxicity","volume":"95","author":"Kreps","year":"2017","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.016_bib0455","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/WNO.0b013e31818f138f","article-title":"Ethambutol optic neuropathy: how we can prevent 100,000 new cases of blindness each year","volume":"28","author":"Sadun","year":"2008","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.jfo.2021.08.016_bib0470","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/15569527.2014.954715","article-title":"Follow-up of retinal nerve fiber layer thickness with optic coherence tomography in patients receiving anti-tubercular treatment may reveal early optic neuropathy","volume":"34","author":"G\u00fcm\u00fc\u015f","year":"2015","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.jfo.2021.08.016_bib0475","doi-asserted-by":"crossref","first-page":"e0204655","DOI":"10.1371\/journal.pone.0204655","article-title":"The use of optical coherence tomography for the detection of ocular toxicity by ethambutol","volume":"13","author":"Pavan Taffner","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jfo.2021.08.016_bib0480","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1128\/CMR.05030-11","article-title":"Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria","volume":"25","author":"Brown-Elliott","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jfo.2021.08.016_bib0485","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijid.2016.03.006","article-title":"Update on pulmonary disease due to non-tuberculous mycobacteria","volume":"45","author":"Stout","year":"2016","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jfo.2021.08.016_bib0490","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1513\/AnnalsATS.201605-353OC","article-title":"Increasing prevalence rate of nontuberculous Mycobacteria infections in five states, 2008\u20132013","volume":"13","author":"Donohue","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jfo.2021.08.016_bib0640","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/bjo.2006.102541","article-title":"Linezolid-induced optic neuropathy: a mitochondrial disorder?","volume":"91","author":"Javaheri","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.016_bib0495","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4103\/0301-4738.77035","article-title":"Toxic optic neuropathy","volume":"59","author":"Sharma","year":"2011","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.016_bib0500","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0140-6736(55)92696-9","article-title":"Optic neuritis following isoniazid therapy","volume":"269","author":"Keeping","year":"1955","journal-title":"Lancet"},{"key":"10.1016\/j.jfo.2021.08.016_bib0505","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/archopht.1962.00960020566009","article-title":"Ocular manifestations of ethambutol, toxic amblyopia after administration of an experimental antituberculous drug","volume":"67","author":"Carr","year":"1962","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.016_bib0465","doi-asserted-by":"crossref","first-page":"e0215297","DOI":"10.1371\/journal.pone.0215297","article-title":"Longitudinal evaluation of visual function and structure for detection of subclinical Ethambutol-induced optic neuropathy","volume":"14","author":"Jin","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jfo.2021.08.016_bib0510","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/01658107.2017.1322616","article-title":"Sibling ethambutol optic chiasmopathy","volume":"42","author":"Jayanetti","year":"2018","journal-title":"Neuroophthalmology"},{"key":"10.1016\/j.jfo.2021.08.016_bib0520","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3109\/15569527.2015.1079784","article-title":"Visual function test for early detection of ethambutol-induced ocular toxicity at the subclinical level","volume":"35","author":"Kim","year":"2016","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.jfo.2021.08.016_bib0460","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1517\/14740338.5.5.615","article-title":"Update on ethambutol optic neuropathy","volume":"5","author":"Fraunfelder","year":"2006","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jfo.2021.08.016_bib0560","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1177\/112067210901900323","article-title":"Early stage ethambutol optic neuropathy: retinal nerve fiber layer and optical coherence tomography","volume":"19","author":"Kim","year":"2009","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.016_bib0565","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1167\/iovs.17-22988","article-title":"Ganglion cell layer and inner plexiform layer as predictors of vision recovery in ethambutol-induced optic neuropathy: a longitudinal OCT analysis","volume":"59","author":"Lee","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2021.08.016_bib0515","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1136\/bjo.2008.148502","article-title":"Prospective evaluation of visual function for early detection of ethambutol toxicity","volume":"93","author":"Menon","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.016_bib0575","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/bjo.2006.113118","article-title":"Decreased retinal nerve fibre layer thickness detected by optical coherence tomography in patients with ethambutol-induced optic neuropathy","volume":"91","author":"Chai","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.016_bib0525","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1016\/j.jfo.2012.12.008","article-title":"H\u00e9mianopsie bitemporale r\u00e9v\u00e9latrice d\u2019une atteinte toxique s\u00e9v\u00e8re \u00e0 l\u2019\u00e9thambutol","volume":"36","author":"Boulanger Scemama","year":"2013","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2021.08.016_bib0530","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/01658107.2016.1173065","article-title":"Spectrum and clinical course of visual field abnormalities in ethambutol toxicity","volume":"40","author":"Mendel","year":"2016","journal-title":"Neuroophthalmology"},{"key":"10.1016\/j.jfo.2021.08.016_bib0535","first-page":"e4408","article-title":"Patterns of ethambutol ocular toxicity in extended use therapy","volume":"11","author":"Mehta","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.jfo.2021.08.016_bib0540","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/WNO.0b013e31818e3ece","article-title":"Multifocal electroretinographic abnormalities in ethambutol-induced visual loss","volume":"28","author":"Liu","year":"2008","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.jfo.2021.08.016_bib0545","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jcjo.2018.06.013","article-title":"Ethambutol-induced optic neuropathy in renal disorder: a clinico-electrophysiological study","volume":"54","author":"Kanaujia","year":"2019","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.016_bib0550","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1001\/archneur.1983.04050090081014","article-title":"Visual evoked potentials in the detection of subclinical optic toxic effects secondary to ethambutol","volume":"40","author":"Yiannikas","year":"1983","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jfo.2021.08.016_bib0570","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00417-004-1053-1","article-title":"Optical coherence tomography can measure axonal loss in patients with ethambutol-induced optic neuropathy","volume":"243","author":"Zoumalan","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.016_bib0650","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/INF.0000000000000589","article-title":"Ethambutol-related impaired visual function in childrens less than 5 years of age treated for a mycobacterial infection: diagnosis and evolution","volume":"34","author":"Levy","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jfo.2021.08.016_bib0645","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00041327-200503000-00005","article-title":"Optic neuropathy associated with linezolid treatment","volume":"25","author":"McKinley","year":"2005","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.jfo.2021.08.016_bib0555","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF00143950","article-title":"Pattern electroretinogram and visual evoked cortical potential in ethambutol optic neuropathy","volume":"67","author":"Kakisu","year":"1987","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.016_bib0580","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/bjophthalmol-2018-312063","article-title":"Diagnostic value of ganglion cell-inner plexiform layer for early detection of ethambutol-induced optic neuropathy","volume":"103","author":"Lee","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.016_bib0585","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/WNO.0000000000000445","article-title":"Re-treatment with ethambutol after toxic optic neuropathy","volume":"37","author":"Bouffard","year":"2017","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.jfo.2021.08.016_bib0590","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/eye.2008.361","article-title":"Multifocal electroretinography changes in patients on ethambutol therapy","volume":"23","author":"Lai","year":"2009","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jfo.2021.08.016_bib0595","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/08820530600987454","article-title":"Abnormal multifocal electroretinogram (mfERG) in ethambutol toxicity","volume":"21","author":"Kardon","year":"2006","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.016_bib0600","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijid.2019.04.028","article-title":"Linezolid interruption in patients with fluoroquinolone-resistant tuberculosis receiving a bedaquiline-based treatment regimen","volume":"85","author":"Olayanju","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jfo.2021.08.016_bib0605","doi-asserted-by":"crossref","first-page":"3128270","DOI":"10.1155\/2018\/3128270","article-title":"Linezolid inhibited synthesis of ATP in mitochondria: based on GC-MS metabolomics and HPLC method","volume":"2018","author":"Ye","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jfo.2021.08.016_bib0610","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/s12879-017-2499-1","article-title":"Peripheral neuropathy in a diabetic child treated with linezolid for multidrug-resistant tuberculosis: a case report and review of the literature","volume":"17","author":"Swaminathan","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jfo.2021.08.016_bib0615","first-page":"61","article-title":"Neuropat\u00eda \u00f3ptica asociada a linezolid: revisi\u00f3n sistem\u00e1tica de casos","volume":"43","author":"Brandariz-N\u00fa\u00f1ez","year":"2019","journal-title":"Farm Hosp"},{"key":"10.1016\/j.jfo.2021.08.016_bib0620","doi-asserted-by":"crossref","first-page":"e9200","DOI":"10.1097\/MD.0000000000009200","article-title":"Linezolid-associated optic neuropathy in a pediatric patient with Mycobacterium nonchromogenicum: a case report","volume":"96","author":"Gonz\u00e1lez Salda\u00f1a","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jfo.2021.08.016_bib0625","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijtb.2016.11.010","article-title":"Linezolid-induced optic neuropathy in XDR pulmonary TB: a case series","volume":"64","author":"Srivastava","year":"2017","journal-title":"Indian J Tuberc"},{"key":"10.1016\/j.jfo.2021.08.016_bib0630","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s10792-016-0196-5","article-title":"Linezolid-induced optic neuropathy with a rare pathological change in the inner retina","volume":"36","author":"Ishii","year":"2016","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.016_bib0635","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/ICB.0000000000000777","article-title":"Linezolid-induced mitochondrial toxicity presenting as retinal nerve fiber layer microcysts and optic and peripheral neuropathy in a patient with chronic granulomatous disease","volume":"15","author":"Pilania","year":"2021","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.jfo.2021.08.016_bib0655","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1136\/bjophthalmol-2012-301870","article-title":"Ethambutol-induced optic neuropathy: a nationwide population-based study from Taiwan","volume":"96","author":"Chen","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2021.08.016_bib0330","doi-asserted-by":"crossref","first-page":"2000535","DOI":"10.1183\/13993003.00535-2020","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official clinical practice guideline","volume":"56","author":"Daley","year":"2020","journal-title":"Eur Respir J"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551221005945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551221005945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:18:04Z","timestamp":1759259884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551221005945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":66,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0181551221005945"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2021.08.016","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"D\u00e9pistage et pr\u00e9vention des neuropathies optiques toxiques aux anti-mycobact\u00e9riens\u00a0: proposition de recommandations","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2021.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}